TrkA was not expressed in a cell. With the finding that proNGF can activate p75 regardless of the presence of TrkA, the ratio of proNGF to mature NGF now emerges 
following spinal cord injury. p75 expression was specifically induced among oligodendrocytes, and the majority of p75 ϩ cells was positive for cleaved caspase 3, suggesting that they were undergoing apoptosis. Corollary to these data, the number of cleaved caspase 3 ϩ oligodendrocytes was reduced after spinal cord injury in the absence of p75. Likewise, the absence of p75 permitted survival of oligodendrocytes under conditions that would otherwise lead to apoptosis both in vivo and in vitro. In addition, we demonstrate that proNGF present in the extracts from the injured spinal cord is active in inducing apoptosis among oligodendrocytes, while its action can be blocked by a proNGF-specific, but not proBDNF-specific, antibody. Together, these results support the hypothesis that a consequence of p75 expression after injury is, in part, to eliminate damaged cells in the CNS, and its activation is mediated predomi- Figure 3B , the majority of oligodendrocytes in the dorsal funiculus was positive for active caspase 3 stain, even at 8 days postinjury. The number of oligodendrocytes positive for active caspase 3 was much reduced in sham-operated animals. Together with the data for p75 and active caspase 3, these results suggest that p75 ϩ oligodendrocytes undergo apoptosis continuously after spinal cord injury.
p75 Is Required for the Apoptosis of Spinal Cord Oligodendrocytes in Culture
We next tested whether ligand-dependent activation of p75 is necessary for apoptosis of spinal cord oligodendrocytes. As the first step, we investigated whether the absence of p75 would render spinal cord oligodendrocytes resistant to NGF-dependent apoptosis by culturing the spinal oligodendrocytes from p75 ϩ/ϩ and p75 Ϫ/Ϫ therefore indicate that p75 is required for NGF-dependent apoptosis in spinal cord oligodendrocytes in culture. operated animals, as was also the case with Western analyses (Figure 2A) Figure 7D ). These results and in the case of proNGF its expression is increased at 0.14 l (350 ng total protein added in 1 ml media) to p75 ϩ/ϩ mouse oligodendrocytes for 24 hr, the proportion of TUNEL ϩ and MBP ϩ cells reached 17%, while it remained at 4% with extracts from sham-operated mice. With p75 Ϫ/Ϫ mouse oligodendrocytes, the proportion of TUNEL ϩ and MBP ϩ cells remained below 4% ( Figure  7A ). This 17% value is very close to that obtained on p75 ϩ/ϩ mouse oligodendrocytes using 100 ng/ml (4 nM) of NGF purified from submaxillary gland ( Figure 4B ). Based on estimation using purified mature NGF as a control in Western analysis, 0.14 l of mouse extracts contains approximately 10-20 ng of proNGF (0.15-0.30 nM) in proNGF concentration. This represents approximately a 13-to 26-fold increase in the action of proNGF on p75 compared to mature NGF, which is comparable to that reported for smooth muscle cells (Lee et al., 2001).
We next compared the activity of proNGF in the spinal cord extracts to that of recombinant proNGF and recombinant mature NGF in oligodendrocytes. Generation and purification of recombinant, cleavage-resistant proNGF and comparably purified mature NGF were previously described (Lee et al., 2001). Within an estimated concentration range from 0.05 nM to 0.5 nM, proNGF in the spinal cord extracts induced apoptosis comparably to recombinant proNGF and more effectively than that observed with recombinant mature NGF ( Figure 7B ). These results therefore suggest that the apoptotic factor present in the injured spinal cord acts via p75, and its dose response suggests that the activity reflects a proneuro- the presence of proNGF antibody, the extent of apoptoinjury. Consistent with these observations, in p75 Ϫ/Ϫ mice after spinal cord injury, there is both a reduction sis was reduced to 2-fold above control ( Figure 7C ). This result suggests that proNGF present in submaxillary in the number of cleaved caspase 3 ϩ oligodendrocytes and an increase in the number of surviving oligodendrogland preparations is largely responsible for its apoptotic action, although it comprises only 2%-6% of total cytes, indicating a predominantly proapoptotic role for p75 activation following injury. We further demonstrated NGF. To directly compare the effects of mature NGF and proNGF, recombinant preparations were utilized (Lee et that this apoptotic action of p75 is likely to be mediated by proNGF in vivo by showing that proNGF in extracts al., 2001) where the mature NGF preparations contained less than 2% proNGF. Utilizing these reagents, mature from the injured spinal cord induces apoptosis of oligodendrocytes in culture at an affinity comparable to that NGF can induce apoptosis of oligodendrocytes but less effectively than proNGF: 0.5 ng/ml of recombinant exhibited by purified, recombinant, cleavage-resistant proNGF. Together, these data provide strong evidence proNGF yielded 23% apoptosis, whereas 50 ng/ml recombinant mature NGF yielded 17% apoptosis ( 
CNS injuries.

Cell Counts Experimental Procedures
All the counts were done blind to mouse genotype or lesion condition. Cell counts were made on rat and mouse coronal sections at Animals Used in the Study a series of rostral and caudal locations relative to the contusion or Mice: two groups of p75 ϩ/ϩ and p75 Ϫ/Ϫ mice were used for the hemisection lesions. Counts and reference volumes were estimated study. For the injury study, a congenic C57/BL6 line that carries a using procedures specified in the Stereologer program (Systems mutation in exon 3 of the p75 gene (Lee et al., 1992) was purchased Planning and Associates, Inc., Alexandria, VA). For rat contusion from the Jackson Laboratory (Bar Harbor, ME). For the culture study, injuries, three sections were randomly sampled from 1 mm blocks the p75 Ϫ/Ϫ and p75 ϩ/ϩ mice were obtained from heterozygote mating taken from 13 and 7 mm rostral and 7 and 13 mm caudal to the as littermates. Their genotype was determined by PCR analyses of lesion epicenter. A pilot study was run to determine the optimal tail DNA according to Bentley and Lee (Bentley and Lee, 2000) . disector size and spacing to allow for counts of at least 100 cells Rats: adult female Long-Evans hooded rats were obtained from per block. CC1 positive cells were only counted when the cell body and proximal processes were darkly labeled and were within the Simonsen Labs (Los Angeles, CA). inclusive zone of each disector frame. Results are reported as total tants expressing pcDNA, pcDNA-proNGF, and pcDNA-mature-NGF were isolated following G418 treatment. For purification, cells were number of oligodendrocytes and as density (number per mm 3 ). Data were gathered from rats with 25 mm spinal cord injury surviving for cultured for 18 hr in serum-free media, and the resulting media were collected after removing cells by centrifugation. His-tagged mature 5 or 8 days (n ϭ 4/time point) or 3 or 6 weeks (n ϭ 3/time point), and control uninjured rats (n ϭ 3). Mouse CC1 ϩ cells were counted or cleavage resistant proNGF was purified using Ni-bead chromatography (Xpress System Protein purification, Invitrogen) as per the in a similar fashion at 8 days postinjury, except that the distance from the lesion center sampled was 1.2 mm and 1.8 mm rostral (R1 manufacturer's instructions using imidazole (350 mM) for elution. Medium from cells stably transfected with pcDNA vector alone was and R2) and 1.2 mm and 1.8 mm caudal (C1 and C2). The number of mice analyzed was n ϭ 6 for p75 ϩ/ϩ and n ϭ 5 for p75 Ϫ/Ϫ . For harvested and purified in parallel. The concentration of proNGF or mature NGF was estimated by silver stain, using known concentraquantification of CC1 ϩ /active caspase 3 ϩ cells in Figure 5B , p75 ϩ/ϩ (n ϭ 5) and p75 Ϫ/Ϫ (n ϭ 5) mice were analyzed at 5 days postinjury, tions of mature NGF (Harlan Bioproducts for science) in parallel. using rostral 4 mm blocks.
Generation of ProNGF-and ProBDNF-Specific Antibodies GST fusion proteins encoding amino acids 23-81 (asp23 to arg81) Primary Oligodendrocyte Cultures of human proNGF or amino acids 25-90 (asn25 to asp90) of human The p75 knockout and the wild-type mice were obtained from hetproBDNF were generated in bacteria and purified by chromatograerozygote mating as littermates. For spinal cord oligodendrocytes phy with glutathione-sepharose. Rabbits (using GST-proNGF) or (Figure 4) , mouse pups at postnatal days 12-14 and for cortical chickens (using GST-proBDNF) were immunized to generate antioligodendrocytes (Figure 7) , mouse pups at postnatal days 15-16 sera. Specific antisera were purified by first incubating whole serum were used. Cell suspension obtained from the triturated tissues was with GST to adsorb GST-specific immunoreactivity and then by loaded onto a 36% Percoll gradient, and oligodendrocytes were adsorption to and elution from a glutathione column to which GSTisolated following centrifugation at 10,000 g blocking experiments, either the injured or sham extracts (0.14 l) were preincubated with mature NGF (5 l; Chemicon), proNGF (5 Western Analyses l), proBDNF (10 l) antibodies, or pre-immune serum (10 l) for 2 The spinal cords were homogenized in a lysis buffer containing 1% hr at 4ЊC. The extract and antibody mix was then added to oligodenNonidet P-40, 20 mM Tris (pH 8.0), 137 mM NaCl, 0.5 mM EDTA, drocytes for 24 hr before they were processed for TUNEL and MBP 10% glycerol, 10 mM Na 2 P 2 O 7 , 10 mM NaF, 1 g/ml aprotinin, 10 stain. g/ml leupeptin, 1 mM vanadate, and 1 mM phenylmethylfulfonyl fluoride. Induction of p75 by spinal cord injury was detected on Statistical Methods Western analyses using an anti-rabbit, anti-p75 antibody from Co-A two-way ANOVA (site ϫ Mowla, S.J., Pareek, S., Farhadi, H.F., Petrecca, K., Fawcett, J.P.,
